# Why In Vivo Therapies Are Moving Toward the Clinic with Ascidian Therapeutics' Dr. Mike Ehlers

Page: https://stenobird.com/podcast/cell-gene-the-podcast-4048431/why-in-vivo-therapies-are-moving-toward-the-clinic-with-ascidian-therapeutics-dr-mike-ehlers
Text version: https://stenobird.com/podcast/cell-gene-the-podcast-4048431/why-in-vivo-therapies-are-moving-toward-the-clinic-with-ascidian-therapeutics-dr-mike-ehlers.md
Podcast: [Cell & Gene: The Podcast](https://stenobird.com/podcast/cell-gene-the-podcast-4048431)
Published: 2026-06-12T09:00:00+00:00
Episode link: https://www.buzzsprout.com/1810482/episodes/19318822-why-in-vivo-therapies-are-moving-toward-the-clinic-with-ascidian-therapeutics-dr-mike-ehlers.mp3
Audio file: https://www.buzzsprout.com/1810482/episodes/19318822-why-in-vivo-therapies-are-moving-toward-the-clinic-with-ascidian-therapeutics-dr-mike-ehlers.mp3
Processing state: not_requested
JSON: https://stenobird.com/v1/public/podcasts/cell-gene-the-podcast-4048431/episodes/why-in-vivo-therapies-are-moving-toward-the-clinic-with-ascidian-therapeutics-dr-mike-ehlers
Duration seconds: 1091

## Resource

We love to hear from our listeners. Send us a message. In Episode 3 of our in vivo-focused special series of Cell & Gene: The Podcast, Ascidian Therapeutics' Founder, President, and CEO Mike Ehlers, M.D., Ph.D., explains how the company is advancing a new class of genetic medicines built on RNA exon editing to durably correct disease at the transcript level without permanently altering DNA. He also shares why in vivo therapies still need to prove precision, durability, and predictability ...

## Actions

- request_transcript: `POST https://stenobird.com/v1/public/podcasts/cell-gene-the-podcast-4048431/episodes/why-in-vivo-therapies-are-moving-toward-the-clinic-with-ascidian-therapeutics-dr-mike-ehlers/transcription-requests` — Idempotently request low-priority transcript generation for this episode.
- read_markdown: `GET https://stenobird.com/podcast/cell-gene-the-podcast-4048431/why-in-vivo-therapies-are-moving-toward-the-clinic-with-ascidian-therapeutics-dr-mike-ehlers.md` — Read the agent-friendly Markdown representation of this episode resource.

A page view does not enqueue transcription. Agents should invoke `request_transcript` explicitly when they need this episode processed.

## Transcript

Full transcripts are not published on public pages unless there is a clear rights basis.